IHC

p16

Identifies a tumor suppressor gene that inhibits the progression of the cell cycle through the G1 phase. Overexpression of the p16 protein has been observed in CIN I, II, and III, where it can serve as a surrogate for the presence of high risk HPV types. The gene is also frequently deleted or mutated in tumors such as melanomas, gliomas, esophageal, pancreatic, lung, and urinary bladder carcinomas, and some types of leukemias. p16 overexpression can also serve as a prognostic marker in the context of head and neck squamous cell carcinomas.

Synonyms

p16-INK4a

Full Description

Identifies a tumor suppressor gene that inhibits the progression of the cell cycle through the G1 phase. Overexpression of the p16 protein has been observed in CIN I, II, and III, where it can serve as a surrogate for the presence of high risk HPV types. The gene is also frequently deleted or mutated in tumors such as melanomas, gliomas, esophageal, pancreatic, lung, and urinary bladder carcinomas, and some types of leukemias. p16 overexpression can also serve as a prognostic marker in the context of head and neck squamous cell carcinomas.

Methodology

IHC

Specimen Requirements

Tissue Block: Formalin-fixed, paraffin-embedded (FFPE) tumor block preferred. Unstained Slides: Recommended 2 charged slides per stain requested (minimum of 1 slide per stain), baked or unbaked. Fixation: Tissue must be fixed in 10% neutral buffered formalin for 6–72 hours.

Storage and Transportation

Use cold pack for transport. Make sure cold pack is not in direct contact with specimen.

Turnaround Time

Global: 48 Hrs, Tech-Only (stain only): 24 Hrs

CPT Codes

88342x1 or 88341x1